Sorenson A, Hresko K, Butcher S, Pierce S, Tramontina V, Leonardi R, Loreto C, Bosio J, Almeida LE. Expression of Interleukin-1 and temporomandibular disorder: Contemporary review of the literature.
Cranio 2017. [PMID:
28629271 DOI:
10.1080/08869634.2017.1342890]
[Citation(s) in RCA: 12] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Abstract
OBJECTIVE
Temporomandibular disorders (TMD) are a group of conditions affecting the temporomandibular joint (TMJ), leading to jaw dysfunction, joint and muscle pain, and a decrease in quality of life. A communication network of pro- and anti-inflammatory mediators called cytokines maintains the homeostasis of the TMJ. This review will focus on the Interleukin (IL) family of cytokines, which have been quantified in TMJ synovial fluids in a variety of studies. IL-1α and IL-1β have pro-inflammatory effects, while the endogenous receptor antagonist (IL-1RA) inhibits the pro-inflammatory effects of IL-1.
METHODS
A literature search (2006-2016) to identify eligible studies was completed using the PubMed database. Studies identified used saline irrigation to quantify cytokine profiles in synovial fluid of healthy and/or dysfunctional joints.
RESULTS
The initial search yielded 111 articles, 5 of which met the inclusion criteria after inter-reviewer discussion.
CONCLUSIONS
Articles that compared IL-1 concentrations in TMD vs. control groups found significant differences.
Collapse